Table 1 Baseline characteristics of the study cohort
Total cohort (n = 77) | Early cIVADs (n = 53) | Late cIVADs (n = 24) | P value | |
|---|---|---|---|---|
Demographics | ||||
Gender, female | 47 (61.0) | 29 (54.7) | 18 (75.0) | 0.091 |
Age on admission, years | 70 (52–76) | 70 (49–77) | 70 (54–76) | 0.830 |
Premorbid mRS | 2 (0–3) | 2 (0–4) | 2 (1–4) | 0.928 |
Median STESS and STESS components | ||||
STESS | 3 (2–4) | 3 (2–5) | 2 (1–4) | 0.106 |
History of seizures | 40 (51.9) | 25 (47.2) | 15 (62.5) | 0.212 |
Stuporous or comatose on admission | 52 (67.5) | 41 (77.4) | 11 (45.8) | 0.006 |
Complex partial SE | 28 (36.4) | 14 (26.4) | 14 (58.3) | 0.007 |
Generalized convulsive SE | 34 (44.2) | 30 (56.6) | 4 (16.7) | 0.001 |
NCSE in coma | 15 (19.5) | 9 (17.0) | 6 (25.0) | 0.535 |
Etiology | ||||
Acute symptomatic | 38 (49.4) | 28 (52.8) | 10 (41.7) | 0.365 |
Remote symptomatic | 18 (23.4) | 11 (20.8) | 7 (29.2) | 0.419 |
Progressive symptomatic | 10 (13.0) | 5 (9.4) | 5 (20.8) | 0.270 |
Unknown | 11 (14.3) | 9 (17.0) | 2 (8.3) | 0.486 |
Potentially fatal | 35 (45.5) | 24 (45.3) | 11 (45.8) | 0.962 |